Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005) of the biparatopic HER2-targeting ...
In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Central ...
(RTTNews) - Drug major Pfizer Inc. (PFE) announced late Monday that it has entered into an exclusive global, ex-China, licensing agreement with Chinese biopharmaceutical company 3SBio, Inc. (TRSBF) ...
Chinese drugmaker Innovent Biologics could receive up to US$11.4 billion from a cancer-drug partnership with Japan's Takeda Pharmaceutical, marking the latest in a wave of tie-ups between Chinese ...
An increasing number of people are dying of colorectal cancer at a young age. The death of actor James Van Der Beek, who was ...
Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over 125,000 ...
Pfizer Inc. (NYSE:PFE) announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.‘s bispecific antibody SSGJ-707 in a deal potentially worth up to $6 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results